PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
153.33%
Revenue growth above 20% indicates exceptional top-line expansion. Peter Lynch would verify if this growth is sustainable and profitable. Cross-check Operating Margins.
-27.15%
Negative cost of revenue growth (cost reduction) can be positive but verify quality impact. Benjamin Graham would examine if cost cuts are sustainable.
73.30%
Gross profit growth above 25% indicates exceptional core profitability improvement. Warren Buffett would verify pricing power and cost control.
89.46%
Gross margin expansion above 5% indicates exceptional pricing power. Warren Buffett would verify competitive moat strength.
8.30%
R&D growth 5-10% suggests significant investment. Howard Marks would investigate if returns justify increased spending.
28.80%
G&A growth above 5% signals concerning overhead expansion. Seth Klarman would demand justification for increased costs.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.70%
Operating expenses growth above 10% signals concerning cost expansion. Seth Klarman would demand justification.
14.70%
Total costs growth above 5% signals concerning expansion. Seth Klarman would demand justification.
-100.00%
Negative interest expense growth needs verification. Benjamin Graham would examine debt reduction strategy.
-27.15%
Negative D&A growth needs verification. Benjamin Graham would examine asset reduction strategy.
-16.20%
Negative EBITDA growth needs thorough analysis. Benjamin Graham would examine operational issues.
54.13%
EBITDA margin growth above 5% demonstrates exceptional operational efficiency. Warren Buffett would verify sustainability.
-15.23%
Negative operating income growth needs thorough analysis. Benjamin Graham would examine operational issues.
54.52%
Operating margin growth above 5% demonstrates exceptional efficiency gains. Warren Buffett would verify sustainability.
98.15%
Other expenses growth above 30% signals concerning expansion. Seth Klarman would scrutinize unusual items.
-12.38%
Negative pre-tax income growth needs thorough analysis. Benjamin Graham would examine operational issues.
55.64%
Pre-tax margin growth above 5% demonstrates exceptional cost management. Warren Buffett would verify sustainability.
-98.15%
Negative tax expense growth needs verification. Benjamin Graham would examine sustainability.
-9.33%
Negative net income growth needs thorough analysis. Benjamin Graham would examine operational issues.
56.84%
Net margin growth above 5% demonstrates exceptional profitability improvement. Warren Buffett would verify sustainability.
-5.41%
Negative EPS growth needs thorough analysis. Benjamin Graham would examine operational issues.
-8.33%
Negative diluted EPS growth needs thorough analysis. Benjamin Graham would examine operational issues.
2.98%
Share increase above 2% signals significant dilution. Seth Klarman would demand explanation.
2.03%
Diluted share increase above 2% signals significant dilution. Seth Klarman would demand explanation.